Literature DB >> 31763714

Heterogeneity of human prostate carcinoma-associated fibroblasts implicates a role for subpopulations in myeloid cell recruitment.

Renee E Vickman1, Meaghan M Broman2, Nadia A Lanman2,3, Omar E Franco1, Putu Ayu G Sudyanti4, Yang Ni5, Yuan Ji6, Brian T Helfand1, Jacqueline Petkewicz1, Michael C Paterakos1, Susan E Crawford1, Timothy L Ratliff2,3, Simon W Hayward1.   

Abstract

BACKGROUND: Carcinoma-associated fibroblasts (CAF) are a heterogeneous group of cells within the tumor microenvironment (TME) that can promote tumorigenesis in the prostate. By understanding the mechanism(s) by which CAF contributes to tumor growth, new therapeutic targets for the management of this disease may be identified. These studies determined whether unique sub-populations of human prostate CAF can be identified and functionally characterized.
METHODS: Single-cell RNA-seq of primary human prostate CAF followed by unsupervised clustering was utilized to generate cell clusters based on differentially expressed (DE) gene profiles. Potential communication between CAF and immune cells was analyzed using in vivo tissue recombination by combining CAF or normal prostate fibroblasts (NPF) with non-tumorigenic, initiated prostate epithelial BPH-1 cells. Resultant grafts were assessed for inflammatory cell recruitment.
RESULTS: Clustering of 3321 CAF allows for visualization of six subpopulations, demonstrating heterogeneity within CAF. Sub-renal capsule recombination assays show that the presence of CAF significantly increases myeloid cell recruitment to resultant tumors. This is supported by significantly increased expression of chemotactic chemokines CCL2 and CXCL12 in large clusters compared to other subpopulations. Bayesian analysis topologies also support differential communication signals between chemokine-related genes of individual clusters. Migration of THP-1 monocyte cells in vitro is stimulated in the presence of CAF conditioned medium (CM) compared with NPF CM. Further in vitro analyses suggest that CAF-derived chemokine CCL2 may be responsible for CAF-stimulated migration of THP-1 cells, since neutralization of this chemokine abrogates migration capacity.
CONCLUSIONS: CAF clustering based on DE gene expression supports the concept that clusters have unique functions within the TME, including a role in immune/inflammatory cell recruitment. These data suggest that CCL2 produced by CAF may be involved in the recruitment of inflammatory cells, but may also directly regulate the growth of the tumor. Further studies aimed at characterizing the subpopulation(s) of CAF which promote immune cell recruitment to the TME and/or stimulate prostate cancer growth and progression will be pursued.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  carcinoma-associated fibroblasts; myeloid cells; single-cell mRNA sequencing; tumor microenvironment

Mesh:

Substances:

Year:  2019        PMID: 31763714     DOI: 10.1002/pros.23929

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  22 in total

1.  The role of microRNAs in the modulation of cancer-associated fibroblasts activity during pancreatic cancer pathogenesis.

Authors:  Lawrence N Barrera; P Matthew Ridley; Camino Bermejo-Rodriguez; Eithne Costello; Pedro A Perez-Mancera
Journal:  J Physiol Biochem       Date:  2022-06-29       Impact factor: 4.158

Review 2.  Fibroblast heterogeneity in prostate carcinogenesis.

Authors:  Sathyavathi ChallaSivaKanaka; Renee E Vickman; Mamatha Kakarla; Simon W Hayward; Omar E Franco
Journal:  Cancer Lett       Date:  2021-10-29       Impact factor: 8.679

Review 3.  Cancer-associated fibroblasts in the single-cell era.

Authors:  Dor Lavie; Aviad Ben-Shmuel; Neta Erez; Ruth Scherz-Shouval
Journal:  Nat Cancer       Date:  2022-07-26

4.  Molecular Characterization of Cancer Associated Fibroblasts in Prostate Cancer.

Authors:  Giovanni Vitale; Michele Caraglia; Volker Jung; Jörn Kamradt; Davide Gentilini; Maria Teresa Di Martino; Alessandra Dicitore; Marianna Abate; Pierosandro Tagliaferri; Annalisa Itro; Matteo Ferro; Raffaele Balsamo; Marco De Sio; Gaetano Facchini; Luca Persani; Kai Schmitt; Matthias Saar; Michael Stöckle; Gerhard Unteregger; Silvia Zappavigna
Journal:  Cancers (Basel)       Date:  2022-06-14       Impact factor: 6.575

Review 5.  Cellular senescence as a possible link between prostate diseases of the ageing male.

Authors:  Gaelle Fiard; Vasilis Stavrinides; Emma S Chambers; Susan Heavey; Alex Freeman; Rhys Ball; Arne N Akbar; Mark Emberton
Journal:  Nat Rev Urol       Date:  2021-07-22       Impact factor: 14.432

Review 6.  Immune Checkpoint Inhibitors: A Promising Treatment Option for Metastatic Castration-Resistant Prostate Cancer?

Authors:  Vicenç Ruiz de Porras; Juan Carlos Pardo; Lucia Notario; Olatz Etxaniz; Albert Font
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

Review 7.  Tumor microenvironment heterogeneity an important mediator of prostate cancer progression and therapeutic resistance.

Authors:  Rongbin Ge; Zongwei Wang; Liang Cheng
Journal:  NPJ Precis Oncol       Date:  2022-05-04

Review 8.  The Etiology and Pathophysiology Genesis of Benign Prostatic Hyperplasia and Prostate Cancer: A New Perspective.

Authors:  Teow J Phua
Journal:  Medicines (Basel)       Date:  2021-06-11

9.  An Unsupervised Strategy for Identifying Epithelial-Mesenchymal Transition State Metrics in Breast Cancer and Melanoma.

Authors:  David J Klinke; Arezo Torang
Journal:  iScience       Date:  2020-04-22

Review 10.  Cancer: a mirrored room between tumor bulk and tumor microenvironment.

Authors:  Pablo Hernández-Camarero; Elena López-Ruiz; Juan Antonio Marchal; Macarena Perán
Journal:  J Exp Clin Cancer Res       Date:  2021-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.